GFAP and diabetic retinopathy: The results in the present study indicated that ATWLPPR had retinal protective effects against vascular injury, oxidative stress and up-regulation of GFAP, VEGF and ICAM-1 in a mouse model of the early stages of experimental diabetic retinopathy.